Supramolecular association in proton‐transfer adducts containing benzamidinium cations. II. Concomitant polymorphs of the molecular salt of 2,6‐dimethoxybenzoic acid with benzamidine

Two concomitant polymorphs of the molecular salt formed by 2,6‐dimethoxybenzoic acid, C₉H₁₀O₄ (Dmb), with benzamidine, C₇H₈N₂ (benzenecarboximidamide, Benzam) from water solution have been identified. Benzamidinidium 2,6‐dimethoxybenzoate, C₇H₉N₂⁺·C₉H₉O₄⁻ (BenzamH⁺·Dmb⁻), was obtained through protonation at the imino N atom of Benzam as a result of proton transfer from the acidic hydroxy group of Dmb. In the monoclinic polymorph, (I) (space group P2₁/n), the asymmetric unit consists of two Dmb⁻ anions and two monoprotonated BenzamH⁺ cations. In the orthorhombic polymorph, (II) (space group P2₁2₁2₁), one Dmb⁻ anion and one BenzamH⁺ cation constitute the asymmetric unit. In both polymorphic salts, the amidinium fragments and carboxylate groups are completely delocalized. This delocalization favours the aggregation of the molecular components of these acid–base complexes into nonplanar dimers with an R²₂(8) graph‐set motif via N⁺—H...O⁻ charge‐assisted hydrogen bonding. Both the monoclinic and orthorhombic forms exhibit one‐dimensional isostructurality, as the crystal structures feature identical hydrogen‐bonding motifs consisting of dimers and catemers.     

Alogliptin and its benzoate salt

The crystal structure of the free base of the antidiabetic drug alogliptin [systematic name: 2‐({6‐[(3R)‐3‐aminopiperidin‐1‐yl]‐3‐methyl‐2,4‐dioxo‐1,2,3,4‐tetrahydropyrimidin‐1‐yl}methyl)benzonitrile], C₁₈H₂₁N₅O₂, displays a two‐dimensional N—H...O hydrogen‐bonded network. It contains two independent molecules, which have the same conformation but differ in their hydrogen‐bond connectivity. In the crystal structure of the benzoate salt (systematic name: (3R)‐1‐{3‐[(2‐cyanophenyl)methyl]‐1‐methyl‐2,6‐dioxo‐1,2,3,6‐tetrahydropyrimidin‐4‐yl}piperidin‐3‐aminium benzoate), C₁₈H₂₂N₅O₂⁺·C₇H₅O₂⁻, the NH₃⁺ group of the cation is engaged in three intermolecular N—H...O hydrogen bonds to yield a hydrogen‐bonded layer structure. The benzoate salt and the free base differ fundamentally in the conformations of their alogliptin moieties.     

Conformational studies of hydantoin‐5‐acetic acid and orotic acid

Hydantoin‐5‐acetic acid [2‐(2,5‐dioxoimidazolidin‐4‐yl)acetic acid] and orotic acid (2,6‐dioxo‐1,2,3,6‐tetrahydropyrimidine‐4‐carboxylic acid) each contain one rigid acceptor–donor–acceptor hydrogen‐bonding site and a flexible side chain, which can adopt different conformations. Since both compounds may be used as coformers for supramolecular complexes, they have been crystallized in order to examine their conformational preferences, giving solvent‐free hydantoin‐5‐acetic acid, C₅H₆N₂O₄, (I), and three crystals containing orotic acid, namely, orotic acid dimethyl sulfoxide monosolvate, C₅H₄N₂O₄·C₂H₆OS, (IIa), dimethylammonium orotate–orotic acid (1/1), C₂H₈N⁺·C₅H₃N₂O₄⁻·C₅H₄N₂O₄, (IIb), and dimethylammonium orotate–orotic acid (3/1), 3C₂H₈N⁺·3C₅H₃N₂O₄⁻·C₅H₄N₂O₄, (IIc). The crystal structure of (I) shows a three‐dimensional network, with the acid function located perpendicular to the ring. Interestingly, the hydroxy O atom acts as an acceptor, even though the carbonyl O atom is not involved in any hydrogen bonds. However, in (IIa), (IIb) and (IIc), the acid functions are only slightly twisted out of the ring planes. All H atoms of the acidic functions are directed away from the rings and, with respect to the carbonyl O atoms, they show an antiperiplanar conformation in (I) and synperiplanar conformations in (IIa), (IIb) and (IIc). Furthermore, in (IIa), (IIb) and (IIc), different conformations of the acid O=C—C—N torsion angle are observed, leading to different hydrogen‐bonding arrangements depending on their conformation and composition.     

Water‐induced pseudo‐quadruple hydrogen‐bonding motifs in xanthine–inorganic acid complexes

In xanthinium nitrate hydrate [systematic name: 2,6‐dioxo‐1,2,3,6‐tetrahydro‐9H‐purin‐7‐ium nitrate monohydrate], C₅H₅N₄O₂⁺·NO₃⁻·H₂O, (I), and xanthinium hydrogen sulfate hydrate [systematic name: 2,6‐dioxo‐1,2,3,6‐tetrahydro‐9H‐purin‐7‐ium hydrogen sulfate monohydrate], C₅H₅N₄O₂⁺·HSO₄⁻·H₂O, (II), the xanthine molecules are protonated at the imine N atom with the transfer of an H atom from the inorganic acid. The asymmetric unit of (I) contains a xanthinium cation, a nitrate anion and one water molecule, while that of (II) contains two crystallographically independent xanthinium cations, two hydrogen sulfate anions and two water molecules. A pseudo‐quadruple hydrogen‐bonding motif is formed between the xanthinium cations and the water molecules via N—H...O and O—H...O hydrogen bonds in both structures, and leads to the formation of one‐dimensional polymeric tapes. These cation–water tapes are further connected by the respective anions and aggregate into two‐dimensional hydrogen‐bonded sheets in (I) and three‐dimensional arrangements in (II).     

Rosiglitazone maleate 0.25‐hydrate: a pseudopolymorphic form

The present 0.25‐hydrated form of rosiglitazone maleate [systematic name: (±)‐2‐({2‐[2,4‐dioxo‐1,3‐thiazolidin‐5‐ylmethyl)phenoxy]ethyl}methylamino)pyridinium maleate 0.25‐hydrate], C₁₈H₂₀N₃O₃S⁺·C₄H₃O₄⁻·0.25H₂O, is a racemate with two independent moieties in the unit cell. Although the cation geometry does not differ substantially from that in the previously reported hydrochloride, the packing is quite different, the main feature being the formation of hydrogen‐bonded tetramers, linked head‐to‐tail into weakly interacting chains.     

Two salts of 5‐sulfosalicylic acid and 3‐aminopyridine

5‐Sulfosalicylic acid (5‐SSA) and 3‐aminopyridine (3‐APy) crystallize in the same solvent system, resulting in two kinds of 1:1 proton‐transfer organic adduct, namely 3‐aminopyridinium 3‐carboxy‐4‐hydroxybenzenesulfonate monohydrate, C₅H₇N₂⁺·C₇H₅O₆S⁻·H₂O or 3‐APy·5‐SSA·H₂O, (I), and the anhydrous adduct, C₅H₇N₂⁺·C₇H₅O₆S⁻ or 3‐APy·5‐SSA, (II). Both compounds have extensively hydrogen‐bonded three‐dimensional layered polymer structures, with interlayer homo‐ and heterogeneous π–π interactions in (I) and (II), respectively.     

6‐Propyl‐2‐thiouracil versus 6‐methoxymethyl‐2‐thiouracil: enhancing the hydrogen‐bonded synthon motif by replacement of a methylene group with an O atom

The understanding of intermolecular interactions is a key objective of crystal engineering in order to exploit the derived knowledge for the rational design of new molecular solids with tailored physical and chemical properties. The tools and theories of crystal engineering are indispensable for the rational design of (pharmaceutical) cocrystals. The results of cocrystallization experiments of the antithyroid drug 6‐propyl‐2‐thiouracil (PTU) with 2,4‐diaminopyrimidine (DAPY), and of 6‐methoxymethyl‐2‐thiouracil (MOMTU) with DAPY and 2,4,6‐triaminopyrimidine (TAPY), respectively, are reported. PTU and MOMTU show a high structural similarity and differ only in the replacement of a methylene group (–CH₂–) with an O atom in the side chain, thus introducing an additional hydrogen‐bond acceptor in MOMTU. Both molecules contain an ADA hydrogen‐bonding site (A = acceptor and D = donor), while the coformers DAPY and TAPY both show complementary DAD sites and therefore should be capable of forming a mixed ADA/DAD synthon with each other, i.e. N—H…O, N—H…N and N—H…S hydrogen bonds. The experiments yielded one solvated cocrystal salt of PTU with DAPY, four different solvates of MOMTU, one ionic cocrystal of MOMTU with DAPY and one cocrystal salt of MOMTU with TAPY, namely 2,4‐diaminopyrimidinium 6‐propyl‐2‐thiouracilate–2,4‐diaminopyrimidine–N,N‐dimethylacetamide–water (1/1/1/1) (the systematic name for 6‐propyl‐2‐thiouracilate is 6‐oxo‐4‐propyl‐2‐sulfanylidene‐1,2,3,6‐tetrahydropyrimidin‐1‐ide), C₄H₇N₄⁺·C₇H₉N₂OS⁻·C₄H₆N₄·C₄H₉NO·H₂O, (I), 6‐methoxymethyl‐2‐thiouracil–N,N‐dimethylformamide (1/1), C₆H₈N₂O₂S·C₃H₇NO, (II), 6‐methoxymethyl‐2‐thiouracil–N,N‐dimethylacetamide (1/1), C₆H₈N₂O₂S·C₄H₉NO, (III), 6‐methoxymethyl‐2‐thiouracil–dimethyl sulfoxide (1/1), C₆H₈N₂O₂S·C₂H₆OS, (IV), 6‐methoxymethyl‐2‐thiouracil–1‐methylpyrrolidin‐2‐one (1/1), C₆H₈N₂O₂S·C₅H₉NO, (V), 2,4‐diaminopyrimidinium 6‐methoxymethyl‐2‐thiouracilate (the systematic name for 6‐methoxymethyl‐2‐thiouracilate is 4‐methoxymethyl‐6‐oxo‐2‐sulfanylidene‐1,2,3,6‐tetrahydropyrimidin‐1‐ide), C₄H₇N₄⁺·C₆H₇N₂O₂S⁻, (VI), and 2,4,6‐triaminopyrimidinium 6‐methoxymethyl‐2‐thiouracilate–6‐methoxymethyl‐2‐thiouracil (1/1), C₄H₈N₅⁺·C₆H₇N₂O₂S⁻·C₆H₈N₂O₂S, (VII). Whereas in (I) only an AA/DD hydrogen‐bonding interaction was formed, the structures of (VI) and (VII) both display the desired ADA/DAD synthon. Conformational studies on the side chains of PTU and MOMTU also revealed a significant deviation for cocrystals (VI) and (VII), leading to the desired enhancement of the hydrogen‐bond pattern within the crystal.     

Structural study of six cycloalkylammonium cinnamate salt structures featuring one‐dimensional columns and two‐dimensional hydrogen‐bonded networks

Six ammonium carboxylate salts, namely cyclopentylammonium cinnamate, C₅H₁₂N⁺·C₉H₇O₂⁻, (I), cyclohexylammonium cinnamate, C₆H₁₄N⁺·C₉H₇O₂⁻, (II), cycloheptylammonium cinnamate form I, C₇H₁₆N⁺·C₉H₇O₂⁻, (IIIa), and form II, (IIIb), cyclooctylammonium cinnamate, C₈H₁₈N⁺·C₉H₇O₂⁻, (IV), and cyclododecylammonium cinnamate, C₁₂H₂₆N⁺·C₉H₇O₂⁻, (V), are reported. Salts (II)–(V) all have a 1:1 ratio of cation to anion and feature three N⁺—H...O⁻ hydrogen bonds forming one‐dimensional hydrogen‐bonded columns consisting of repeating R₄³(10) rings, while salt (I) has a two‐dimensional network made up of alternating R₄⁴(12) and R⁶₈(20) rings. Salt (III) consists of two polymorphic forms, viz. form I having Z′ = 1 and form II with Z′ = 2. The latter polymorph has disorder of the cycloheptane rings in the two cations, as well as whole‐molecule disorder of one of the cinnamate anions. A similar, but ordered, Z′ = 2 structure is seen in salt (IV).     

Eight salt forms of sulfadiazine

Proton transfer to the sulfa drug sulfadiazine [systematic name: 4‐amino‐N‐(pyrimidin‐2‐yl)benzenesulfonamide] gave eight salt forms. These are the monohydrate and methanol hemisolvate forms of the chloride (2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium chloride monohydrate, C₁₀H₁₁N₄O₂S⁺·Cl⁻·H₂O, (I), and 2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium chloride methanol hemisolvate, C₁₀H₁₁N₄O₂S⁺·Cl⁻·0.5CH₃OH, (II)); a bromide monohydrate (2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium bromide monohydrate, C₁₀H₁₁N₄O₂S⁺·Br⁻·H₂O, (III)), which has a disordered water channel; a species containing the unusual tetraiodide dianion [bis(2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium) tetraiodide, 2C₁₀H₁₁N₄O₂S⁺·I₄²⁻, (IV)], where the [I₄]²⁻ ion is located at a crystallographic inversion centre; a tetrafluoroborate monohydrate (2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium tetrafluoroborate monohydrate, C₁₀H₁₁N₄O₂S⁺·BF₄⁻·H₂O, (V)); a nitrate (2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium nitrate, C₁₀H₁₁N₄O₂S⁺·NO₃⁻, (VI)); an ethanesulfonate {4‐[(pyrimidin‐2‐yl)sulfamoyl]anilinium ethanesulfonate, C₁₀H₁₁N₄O₂S⁺·C₂H₅SO₃⁻, (VII)}; and a dihydrate of the 4‐hydroxybenzenesulfonate {4‐[(pyrimidin‐2‐yl)sulfamoyl]anilinium 4‐hydroxybenzenesulfonate dihydrate, C₁₀H₁₁N₄O₂S⁺·HOC₆H₄SO₃⁻·2H₂O, (VIII)}. All these structures feature alternate layers of cations and of anions where any solvent is associated with the anion layers. The two sulfonate salts are protonated at the aniline N atom and the amide N atom of sulfadiazine, a tautomeric form of the sulfadiazine cation that has not been crystallographically described before. All the other salt forms are instead protonated at the aniline group and on one N atom of the pyrimidine ring. Whilst all eight species are based upon hydrogen‐bonded centrosymetric dimers with graph set R₂²(8), the two sulfonate structures also differ in that these dimers do not link into one‐dimensional chains of cations through NH₃‐to‐SO₂ hydrogen‐bonding interactions, whilst the other six species do. The chloride methanol hemisolvate and the tetraiodide are isostructural and a packing analysis of the cation positions shows that the chloride monohydrate structure is also closely related to these.     

One barbiturate and two solvated thiobarbiturates containing the triply hydrogen‐bonded ADA/DAD synthon,plus one ansolvate and three solvates of their coformer 2,4‐diaminopyrimidine

A path to new synthons for application in crystal engineering is the replacement of a strong hydrogen‐bond acceptor, like a C=O group, with a weaker acceptor, like a C=S group, in doubly or triply hydrogen‐bonded synthons. For instance, if the C=O group at the 2‐position of barbituric acid is changed into a C=S group, 2‐thiobarbituric acid is obtained. Each of the compounds comprises two ADA hydrogen‐bonding sites (D = donor and A = acceptor). We report the results of cocrystallization experiments of barbituric acid and 2‐thiobarbituric acid, respectively, with 2,4‐diaminopyrimidine, which contains a complementary DAD hydrogen‐bonding site and is therefore capable of forming an ADA/DAD synthon with barbituric acid and 2‐thiobarbituric acid. In addition, pure 2,4‐diaminopyrimidine was crystallized in order to study its preferred hydrogen‐bonding motifs. The experiments yielded one ansolvate of 2,4‐diaminopyrimidine (pyrimidine‐2,4‐diamine, DAPY), C₄H₆N₄, (I), three solvates of DAPY, namely 2,4‐diaminopyrimidine–1,4‐dioxane (2/1), 2C₄H₆N₄·C₄H₈O₂, (II), 2,4‐diaminopyrimidine–N,N‐dimethylacetamide (1/1), C₄H₆N₄·C₄H₉NO, (III), and 2,4‐diaminopyrimidine–1‐methylpyrrolidin‐2‐one (1/1), C₄H₆N₄·C₅H₉NO, (IV), one salt of barbituric acid, viz. 2,4‐diaminopyrimidinium barbiturate (barbiturate is 2,4,6‐trioxopyrimidin‐5‐ide), C₄H₇N₄⁺·C₄H₃N₂O₃⁻, (V), and two solvated salts of 2‐thiobarbituric acid, viz. 2,4‐diaminopyrimidinium 2‐thiobarbiturate–N,N‐dimethylformamide (1/2) (2‐thiobarbiturate is 4,6‐dioxo‐2‐sulfanylidenepyrimidin‐5‐ide), C₄H₇N₄⁺·C₄H₃N₂O₂S⁻·2C₃H₇NO, (VI), and 2,4‐diaminopyrimidinium 2‐thiobarbiturate–N,N‐dimethylacetamide (1/2), C₄H₇N₄⁺·C₄H₃N₂O₂S⁻·2C₄H₉NO, (VII). The ADA/DAD synthon was succesfully formed in the salt of barbituric acid, i.e. (V), as well as in the salts of 2‐thiobarbituric acid, i.e. (VI) and (VII). In the crystal structures of 2,4‐diaminopyrimidine, i.e. (I)–(IV), R₂²(8) N—H…N hydrogen‐bond motifs are preferred and, in two structures, additional R₃²(8) patterns were observed.     

The structure of the 1H‐imidazol‐3‐ium lawsonate salt aided by ab initio gas‐phase calculations

For the new organic salt 1H‐imidazol‐3‐ium 1,4‐dioxo‐1,4‐dihydronaphthalen‐2‐olate, C₃H₅N₂⁺·C₁₀H₅O₃⁻, ab initio calculations of the gas‐phase structures of the lawsonate and imidazolium ions were performed to help in the interpretation of the structural features observed. Three different types of hydrogen bond are responsible for the three‐dimensional packing of the salt.     

The 1:1 cocrystals of the proton‐transfer compound dilituric acid–phenyl­biguanide monohydrate

A proton‐transfer compound, 1‐phenyl­biguanidium 5‐nitro‐2,6‐dioxo‐1,2,3,6‐tetra­hydro­pyrimidin‐4‐olate monohydrate, C₈H₁₂N₅⁺·C₄H₂N₃O₅⁻·H₂O, has been synthesized by a reaction between dilituric acid (5‐nitro‐2,4,6‐trihydroxy­pyrimi­dine, Dilit) and phenyl­biguanide (N‐phenyl­imido­carbonimidic diamide, Big). This compound cocrystallized as a 1:1 adduct, and the asymmetric unit consists of two dilituric amino–oxo planar tautomeric anions (Dilit⁻), two monoprotonated phenyl­biguanidium cations (BigH⁺) and two water mol­ecules of crystallization (Z′ = 2). Protonation occurs at the N atom attached to the phenyl ring of Big as a result of the proton‐transfer process from the acidic hydr­oxy group of Dilit. In the crystal structure, the hydrated 1:1 adduct is stabilized by 25 two‐ and three‐center hydrogen bonds.     

Purine 3′:5′‐cyclic nucleotides with the nucleobase in a syn orientation: cAMP,cGMP and cIMP

Purine 3′:5′‐cyclic nucleotides are very well known for their role as the secondary messengers in hormone action and cellular signal transduction. Nonetheless, their solid‐state conformational details still require investigation. Five crystals containing purine 3′:5′‐cyclic nucleotides have been obtained and structurally characterized, namely adenosine 3′:5′‐cyclic phosphate dihydrate, C₁₀H₁₂N₅O₆P·2H₂O or cAMP·2H₂O, (I), adenosine 3′:5′‐cyclic phosphate 0.3‐hydrate, C₁₀H₁₂N₅O₆P·0.3H₂O or cAMP·0.3H₂O, (II), guanosine 3′:5′‐cyclic phosphate pentahydrate, C₁₀H₁₂N₅O₇P·5H₂O or cGMP·5H₂O, (III), sodium guanosine 3′:5′‐cyclic phosphate tetrahydrate, Na⁺·C₁₀H₁₁N₅O₇P⁻·4H₂O or Na(cGMP)·4H₂O, (IV), and sodium inosine 3′:5′‐cyclic phosphate tetrahydrate, Na⁺·C₁₀H₁₀N₄O₇P⁻·4H₂O or Na(cIMP)·4H₂O, (V). Most of the cyclic nucleotide zwitterions/anions [two from four cAMP present in total in (I) and (II), cGMP in (III), cGMP⁻ in (IV) and cIMP⁻ in (V)] are syn conformers about the N‐glycosidic bond, and this nucleobase arrangement is accompanied by C_rib—H…N_pur hydrogen bonds (rib = ribose and pur = purine). The base orientation is tuned by the ribose pucker. An analysis of data obtained from the Cambridge Structural Database made in the context of syn–anti conformational preferences has revealed that among the syn conformers of various purine nucleotides, cyclic nucleotides and dinucleotides predominate significantly. The interactions stabilizing the syn conformation have been indicated. The inter‐nucleotide contacts in (I)–(V) have been systematized in terms of the chemical groups involved. All five structures display three‐dimensional hydrogen‐bonded networks.     

Brucine salts of l‐α‐hydr­oxy acids: brucinium hydrogen (S)‐malate penta­hydrate and anhydrous brucinium hydrogen (2R,3R)‐tartrate at 130 K

The structures of two brucinium (2,3‐dimeth­oxy‐10‐oxostrychnidinium) salts of the α‐hydr­oxy acids l ‐malic acid and l ‐tartaric acid, namely brucinium hydrogen (S)‐malate penta­hydrate, C₂₃H₂₇N₂O₄⁺·C₄H₅O₅⁻·5H₂O, (I), and anhydrous brucinium hydrogen (2R,3R)‐tartrate, C₂₃H₂₇N₂O₄⁺·C₄H₅O₆⁻,(II), have been determined at 130 K. Compound (I) has two brucinium cations, two hydrogen malate anions and ten water mol­ecules of solvation in the asymmetric unit, and forms an extensively hydrogen‐bonded three‐dimensional framework structure. In compound (II), the brucinium cations form the common undulating brucine sheet substructures, which accommodate parallel chains of head‐to‐tail hydrogen‐bonded tartrate anion species in the inter­stitial cavities.     

Brucinium 3,5‐dinitro­benzoate methanol solvate,methanol disolvate and trihydrate

Crystals of brucinium 3,5‐dinitro­benzoate methanol solvate, C₂₃H₂₇N₂O₄⁺·C₇H₃N₂O₆⁻·CH₃OH, (I), brucinium 3,5‐dinitro­benzoate methanol disolvate, C₂₃H₂₇N₂O₄⁺·C₇H₃N₂O₆⁻·2CH₃OH, (II), and brucinium 3,5‐dinitro­benzoate trihydrate, C₂₃H₂₇N₂O₄⁺·C₇H₃N₂O₆⁻·3H₂O, (III), were obtained from methanol [for (I) and (II)] or ethanol solutions [for (III)]. The brucinium cations and 3,5‐dinitro­benzoate anions are linked by ionic N—H⁺⋯O⁻ hydrogen bonds. In the crystals of (I), (II) and (III), the brucinium cations exhibit different modes of packing, viz. corrugated ribbons, pillars and corrugated monolayer sheets, respectively. While in (III), the amide O atom of the brucinium cation participates in O—H⋯O hydrogen bonds, in which water mol­ecules are the donors, in (I) and (II), the amide O atom of the brucinium cation is involved in weak C—H⋯O hydrogen bonds and other brucinium cations are the donors.     

Six two‐ and three‐component ammonium carboxylate salt structures with a ladder‐type hydrogen‐bonding motif,three incorporating neutral carboxylic acid molecules

Six ammonium carboxylate salts are synthesized and reported, namely 2‐propylammonium benzoate, C₃H₁₀N⁺·C₇H₅O₂⁻, (I), benzylammonium (R)‐2‐phenylpropionate, C₆H₁₀N⁺·C₉H₉O₂⁻, (II), (RS)‐1‐phenylethylammonium naphthalene‐1‐carboxylate, C₈H₁₂N⁺·C₁₁H₇O₂⁻, (III), benzylammonium–benzoate–benzoic acid (1/1/1), C₆H₁₀N⁺·C₇H₅O₂⁻·C₇H₆O₂, (IV), cyclopropylammonium–benzoate–benzoic acid (1/1/1), C₃H₈N⁺·C₇H₅O₂⁻·C₇H₆O₂, (V), and cyclopropylammonium–ea‐cis‐cyclohexane‐1,4‐dicarboxylate–ee‐trans‐cyclohexane‐1,4‐dicarboxylic acid (2/1/1), 2C₃H₈N⁺·C₈H₁₀O₄²⁻·C₈H₁₂O₄, (VI). Salts (I)–(III) all have a 1:1 ratio of cation to anion and feature three N⁺—H...O⁻ hydrogen bonds which form one‐dimensional hydrogen‐bonded ladders. Salts (I) and (II) have type II ladders, consisting of repeating R₄³(10) rings, while (III) has type III ladders, in this case consisting of alternating R₄²(8) and R₄⁴(12) rings. Salts (IV) and (V) have a 1:1:1 ratio of cation to anion to benzoic acid. They have type III ladders formed by three N⁺—H...O⁻ hydrogen bonds, while the benzoic acid molecules are pendant to the ladders and hydrogen bond to them via O—H...O⁻ hydrogen bonds. Salt (VI) has a 2:1:1 ratio of cation to anion to acid and does not feature any hydrogen‐bonded ladders; instead, the ionized and un‐ionized components form a three‐dimensional network of hydrogen‐bonded rings. The two‐component 1:1 salts are formed from a 1:1 ratio of amine to acid. To create the three‐component salts (IV)–(VI), the ratio of amine to acid was reduced so as to deprotonate only half of the acid molecules, and then to observe how the un‐ionized acid molecules are incorporated into the ladder motif. For (IV) and (V), the ratio of amine to acid was reduced to 1:2, while for (VI) the ratio of amine to acid required to deprotonate only half the diacid molecules was 1:1.     

Supramolecular hydrogen‐bonded networks in cytosinium succinate and cytosinium 4‐nitrobenzoate cytosine monohydrate

In cytosinium succinate (systematic name: 4‐amino‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium 3‐carboxypropanoate), C₄H₆N₃O⁺·C₄H₅O₄⁻, (I), the cytosinium cation forms one‐dimensional self‐assembling patterns by intermolecular N—H...O hydrogen bonding, while in cytosinium 4‐nitrobenzoate cytosine monohydrate [systematic name: 4‐amino‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium 4‐nitrobenzoate 4‐aminopyrimidin‐2(1H)‐one solvate monohydrate], C₄H₆N₃O⁺·C₇H₄NO₄⁻·C₄H₅N₃O·H₂O, (II), the cytosinium–cytosine base pair, held together by triple hydrogen bonds, leads to one‐dimensional polymeric ribbons via double N—H...O hydrogen bonds. This study illustrates clearly the different alignment of cytosine molecules in the crystal packing and their ability to form supramolecular hydrogen‐bonded networks with the anions.     

Strychninium N‐phthaloyl‐β‐alaninate N‐phthaloyl‐β‐alanine and brucinium N‐phthaloyl‐β‐alaninate 5.67‐hydrate

Comparison of the structures of strychninium N‐phthaloyl‐β‐alaninate N‐phthaloyl‐β‐alanine, C₂₁H₂₃N₂O₂⁺·C₁₁H₈NO₄⁻·C₁₁H₉NO₄, and brucinium N‐phthaloyl‐β‐alaninate 5.67‐hydrate, C₂₃H₂₇N₂O₄⁺·C₁₁H₈NO₄⁻·5.67H₂O, reveals that, unlike strychninium cations, brucinium cations display a tendency to produce stacking inter­actions with cocrystallizing guests.     

Hydro­gen bonding in proton‐transfer compounds of 5‐sulfosalicylic acid with bicyclic heteroaromatic Lewis bases

The crystal structures of quinolinium 3‐carboxy‐4‐hydroxy­benzene­sulfonate trihydrate, C₉H₈N⁺·C₇H₅O₆S⁻·3H₂O, (I), 8‐hydroxy­quinolinium 3‐carboxy‐4‐hydroxy­benzene­sulfonate monohydrate, C₉H₈NO⁺·C₇H₅O₆S⁻·H₂O, (II), 8‐amino­quinolinium 3‐carboxy‐4‐hydroxy­benzene­sulfonate dihydrate, C₉H₉N₂⁺·C₇H₅O₆S⁻·2H₂O, (III), and 2‐carboxy­quinolinium 3‐carboxy‐4‐hydroxy­benzene­sulfonate quinolinium‐2‐carboxylate, C₁₀H₈NO₂⁺·C₇H₅O₆S⁻·C₁₀H₇NO₂, (IV), four proton‐transfer compounds of 5‐sulfosalicylic acid with bicyclic heteroaromatic Lewis bases, reveal in each the presence of variously hydrogen‐bonded polymers. In only one of these compounds, viz. (II), is the protonated quinolinium group involved in a direct primary N⁺—H⋯O(sulfonate) hydrogen‐bonding interaction, while in the other hydrates, viz. (I) and (III), the water mol­ecules participate in the primary intermediate interaction. The quinaldic acid (quinoline‐2‐carboxylic acid) adduct, (IV), exhibits cation–cation and anion–adduct hydrogen bonding but no direct formal heteromolecular interaction other than a number of weak cation–anion and cation–adduct π–π stacking associations. In all other compounds, secondary interactions give rise to network polymer structures.     

7‐Methoxy‐2,3‐dioxo‐1,4‐dihydroquinoxalin‐6‐aminium chloride monohydrate

Single crystals of the title compound, C₉H₁₀N₃O₃⁺·Cl⁻·H₂O, were obtained by recrystallization from hydrochloric acid. The cations stack along the crystallographic a direction. The 2,3‐dioxo‐1,4‐dihydroquinoxaline group shows a significant deviation from planarity [r.m.s. deviation from the best plane = 0.063 (2) Å]. Hydrogen bonding links the cations, chloride anions and water molecules to form an extended three‐dimensional architecture.